Immediate and Delayed Reactions to Trauma-related Laboratory Research Among Rape Survivors and Controls

June 23, 2021 Leave a comment
Moral implications of laboratory-based experimental trauma analysis are usually not properly studied. Feminine rape survivors (N = 62) and controls (N = 79) listened to an audio recording of a sexual assault and accomplished psychological well being measures and the Reactions to Analysis Participation Questionnaire-Revised within the first session and once more a number of weeks later.
Within the first session, psychological well being signs had been related to stronger emotional reactions and private advantages from participation. Rape survivors additionally reported stronger emotional reactions than controls, but additionally extra private advantages, extra satisfaction, and fewer perceived drawbacks from participation. A number of weeks later, each teams reported diminished posttraumatic stress dysfunction signs and rape survivors’ stories of stronger emotional reactions and better satisfaction with their participation remained vital. Profit-cost ratios point out optimistic responses to participation throughout teams and time. Findings recommend vital advantages to laboratory trauma analysis for contributors.

Worldwide Rickettsia Illness Surveillance: An Instance of Cooperative Analysis to Enhance Laboratory Functionality and Capability for Threat Evaluation of Rickettsial Outbreaks Worldwide

Cooperative analysis that addresses infectious illness surveillance and outbreak investigations depends closely on availability and efficient use of acceptable diagnostic instruments, together with serological and molecular assays, as exemplified by the present COVID-19 pandemic. On this paper, we stress the significance of utilizing these assays to assist collaborative epidemiological research to evaluate danger of rickettsial illness outbreaks amongst worldwide associate international locations.
Workforce improvement, mentorship, and coaching are essential elements in constructing laboratory functionality and capability to evaluate danger of and mitigate rising illness outbreaks. Worldwide partnerships that fund cooperative analysis by means of mentoring and on-the-job coaching are profitable examples for enhancing infectious illness surveillance. Cooperative analysis research between the Naval Medical Analysis Heart’s Rickettsial Ailments Analysis Program (RDRP) and 17 institutes from 9 international locations amongst 5 continents had been performed to deal with the presence of and the danger for endemic rickettsial illnesses.
To determine serological and molecular assays within the collaborative institutes, preliminary coaching and continued materials, and technical assist had been supplied by RDRP. The laboratory strategies used within the analysis research to detect and establish the rickettsial infections included (1) group-specific IgM and IgG serological assays and (2) molecular assays.
Twenty-six cooperative analysis initiatives carried out between 2008 and 2020 enhanced the potential and capability of 17 analysis institutes to estimate danger of rickettsial illnesses. These worldwide collaborative research have led to the popularity and/or affirmation of rickettsial illnesses inside every of the associate international locations. As well as, with the identification of particular pathogen and non-pathogen Rickettsia species, a extra correct danger evaluation may very well be made in surveillance research utilizing environmental samples.
The discoveries from these initiatives bolstered worldwide cooperation benefiting not solely the associate international locations but additionally the scientific group at massive by means of shows (n = 40) at worldwide scientific conferences and peer-reviewed publications (n = 18). The cooperative analysis research performed in a number of worldwide institutes led to the incorporation of latest SOPs and trainings for laboratory procedures; biosafety, biosurety, and biosecurity strategies; efficiency of rickettsia-specific assays; and the identification of identified and unknown rickettsial brokers by means of the introduction of latest serologic and molecular assays that complemented conventional microbiology strategies.
Immediate and Delayed Reactions to Trauma-related Laboratory Research Among Rape Survivors and Controls

Laboratory Preparation of Monochloramine for Environmental Analysis: A Comparability of 4 Generally Used Protocols

Monochloramine (MCA) is commonly used as a secondary disinfectant in ingesting water distribution techniques (DWDS) for controlling the regrowth of microorganisms. Laboratory experiments to check the efficacy of MCA and formation of disinfection byproducts in DWDS all require the preparation of MCA. Completely different protocols for the preparation of MCA have been used within the literature.
On this research, we in contrast 4 printed protocols which can be ceaselessly used to arrange MCA within the environmental analysis group. Our outcomes confirmed that the selection of protocol might end in substantial variations in decay kinetics and disinfection efficacy of the ready MCA. The discrepancies spotlight a direct want for the standardization of MCA preparation protocols for laboratory-scale ingesting water analysis.

Human Laboratory Fashions of Hashish Use: Functions for Medical and Translational Psychiatry Analysis

Hashish is more and more utilized by people with psychological well being diagnoses and sometimes presupposed to deal with anxiousness and varied different psychiatric signs. But assist for utilizing hashish as a psychiatric remedy is at present restricted by a scarcity of proof from rigorous placebo-controlled research. Whereas regulatory hurdles and different boundaries make scientific trials of hashish difficult to conduct, dependancy researchers have a long time of expertise finding out hashish use in human laboratory fashions. These embrace strategies to manage hashish administration, to delineate scientific and mechanistic elements of hashish use, and to guage potential remedy functions for hashish and its constituents.
On this paper, we overview these human laboratory procedures and describe how every may be utilized to check hashish use in sufferers with psychiatric issues. As a result of anxiousness issues are among the many most typical psychiatric sicknesses affecting American adults, and anxiousness reduction can also be essentially the most commonly-reported purpose for medicinal hashish use, we focus notably on making use of human laboratory fashions to check hashish results in people with anxiousness and associated issues. Lastly, we focus on how these strategies may be built-in to check hashish results in different psychiatric situations and information future analysis on this space.

The intestine microbiome of laboratory mice: concerns and finest practices for translational analysis

Simply because the intestine microbiota (GM) is now acknowledged as an integral mediator of environmental influences on human physiology, susceptibility to illness, and response to pharmacological intervention, so too does the GM of laboratory mice have an effect on the phenotype of analysis utilizing mouse fashions. A number of experimental elements have been proven to have an effect on the composition of the GM in analysis mice, in addition to the mannequin phenotype, suggesting that the GM represents a significant element in experimental reproducibility.

Progesterone Receptor Antibody
49338-50ul 50ul
EUR 286.8

Progesterone receptor antibody
70R-13656 100 ul
EUR 548.4
Description: Affinity purified Rabbit polyclonal Progesterone receptor antibody

Progesterone Receptor antibody
70R-32466 100 ug
EUR 392.4
Description: Rabbit polyclonal Progesterone Receptor antibody

Progesterone Receptor antibody
70R-32467 100 ug
EUR 392.4
Description: Rabbit polyclonal Progesterone Receptor antibody

Progesterone Receptor antibody
70R-37509 100 ug
EUR 327.6
Description: Rabbit Polyclonal Progesterone Receptor antibody

Progesterone Receptor antibody
70R-50201 100 ul
EUR 344.4
Description: Purified Polyclonal Progesterone Receptor antibody

Progesterone Receptor Antibody
ABF6106 100 ug
EUR 525.6

Progesterone Receptor Antibody
ABF6107 100 ug
EUR 525.6

Progesterone Receptor Antibody
DF6829 200ul
EUR 420

Progesterone Receptor Antibody
F40307-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined.

Progesterone Receptor Antibody
F40307-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined.

Progesterone Receptor Antibody
F42683-0.08ML 0.08 ml
EUR 140.25
Description: As demonstrated in PR-deficient mice, the physiological effects of progesterone depend completely on the presence of its receptor (hPR), a member of the steroid-receptor superfamily of nuclear receptors. The single-copy hPR gene uses separate promoters and translational start sites to produce two isoforms, hPR-A and -B, which are identical except for an additional 165 amino acids present only in the N terminus of -B. Although hPR-B shares many important structural domains as -A, they are in fact two functionally distinct transcription factors, mediating their own response genes and physiological effects with little overlap. Selective ablation of PR-A in a mouse model, resulting in exclusive production of -B, unexpectedly revealed that -B contributes to, rather than inhibits, epithelial cell proliferation both in response to estrogen alone and in the presence of progesterone and estrogen. These results suggest that in the uterus, the PR-A isoform is necessary to oppose estrogen-induced proliferation as well as -B-dependent proliferation. [Wiki]

Progesterone Receptor Antibody
F42683-0.4ML 0.4 ml
EUR 322.15
Description: As demonstrated in PR-deficient mice, the physiological effects of progesterone depend completely on the presence of its receptor (hPR), a member of the steroid-receptor superfamily of nuclear receptors. The single-copy hPR gene uses separate promoters and translational start sites to produce two isoforms, hPR-A and -B, which are identical except for an additional 165 amino acids present only in the N terminus of -B. Although hPR-B shares many important structural domains as -A, they are in fact two functionally distinct transcription factors, mediating their own response genes and physiological effects with little overlap. Selective ablation of PR-A in a mouse model, resulting in exclusive production of -B, unexpectedly revealed that -B contributes to, rather than inhibits, epithelial cell proliferation both in response to estrogen alone and in the presence of progesterone and estrogen. These results suggest that in the uterus, the PR-A isoform is necessary to oppose estrogen-induced proliferation as well as -B-dependent proliferation. [Wiki]

Progesterone Receptor Antibody
F47198-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined.

Progesterone Receptor Antibody
F47595-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined.

Progesterone Receptor Antibody
F47595-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined.

Progesterone Receptor Antibody
F47596-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. The location of transcription initiation for isoform A has not been clearly determined.

Progesterone Receptor Antibody
R30483 100 ug
EUR 356.15
Description: The progesterone receptor(PR) is an intracellular steroid receptor that specially binds progesterone in humans. PR has been a member of the steroid receptor superfamily. It is encoded by a single PGR gene residing on chromosome 11q22. The PGR gene uses separate promoters and translational start sites to produce 2 isoforms, PRA and PRB, which are identical except for an additional 165 amino acids present only in the N terminus of PRB. It can be observed in human breast tissues. The proteins function as dimeric molecules in nuclei to regulate the transcription of target genes in a ligand-responsive manner.

Progesterone Receptor Antibody
R31442 100 ug
EUR 356.15
Description: The progesterone receptor (PR) is an intracellular steroid receptor that specially binds progesterone in humans. It is encoded by a single PGR gene residing on chromosome 11q22. The PR gene uses separate promoters and translational start sites to produce 2 isoforms, PRA and PRB, which are identical except for an additional 165 amino acids present only in the N terminus of PRB. It can be observed in human breast tissues. The proteins function as dimeric molecules in nuclei to regulate the transcription of target genes in a ligand-responsive manner.

Progesterone Receptor Antibody
RQ5142 100ul
EUR 356.15
Description: The PGR gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce several transcript variants, both protein coding and non-protein coding. Two of the isoforms (A and B) are identical except for an additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap. [RefSeq]

Progesterone Receptor Antibody
V8885-100UG 100ug
EUR 349.3
Description: Progesterone is one of the central regulators of female reproduction. In breast development, progesterone is involved in the formation of lobular-alveolar structures and also affects differentiation in the breast by modulation of milk protein synthesis. The cellular effects of progesterone are mediated through progesterone receptors (PR). PR, a protein with 946 amino acids, is a ligand-activated transcription factor member of the steroid receptor super family of nuclear receptors. PR is predominantly expressed in female sex steroid responsive tissues such as the mammary gland, uterus and ovary but is also found in other tissues such as endocrine cells of the Langerhans islets. The estrogen receptor (ER) and PR status has been used for over 20 years as a predictor of breast carcinoma responsiveness to endocrine therapy and as a prognostic indicator for early recurrence.

Progesterone Receptor Antibody
V8885-20UG 20ug
EUR 153.3
Description: Progesterone is one of the central regulators of female reproduction. In breast development, progesterone is involved in the formation of lobular-alveolar structures and also affects differentiation in the breast by modulation of milk protein synthesis. The cellular effects of progesterone are mediated through progesterone receptors (PR). PR, a protein with 946 amino acids, is a ligand-activated transcription factor member of the steroid receptor super family of nuclear receptors. PR is predominantly expressed in female sex steroid responsive tissues such as the mammary gland, uterus and ovary but is also found in other tissues such as endocrine cells of the Langerhans islets. The estrogen receptor (ER) and PR status has been used for over 20 years as a predictor of breast carcinoma responsiveness to endocrine therapy and as a prognostic indicator for early recurrence.

Progesterone Receptor Antibody
V8885SAF-100UG 100ug
EUR 349.3
Description: Progesterone is one of the central regulators of female reproduction. In breast development, progesterone is involved in the formation of lobular-alveolar structures and also affects differentiation in the breast by modulation of milk protein synthesis. The cellular effects of progesterone are mediated through progesterone receptors (PR). PR, a protein with 946 amino acids, is a ligand-activated transcription factor member of the steroid receptor super family of nuclear receptors. PR is predominantly expressed in female sex steroid responsive tissues such as the mammary gland, uterus and ovary but is also found in other tissues such as endocrine cells of the Langerhans islets. The estrogen receptor (ER) and PR status has been used for over 20 years as a predictor of breast carcinoma responsiveness to endocrine therapy and as a prognostic indicator for early recurrence.

Progesterone Receptor Antibody
V9066-100UG 100 ug
EUR 349.3
Description: This mAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V9066-20UG 20 ug
EUR 153.3
Description: This mAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V9066IHC-7ML 7 ml
EUR 349.3
Description: This mAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V9066SAF-100UG 100 ug
EUR 349.3
Description: This mAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V7038-100UG 100 ug
EUR 349.3
Description: Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V7038-20UG 20 ug
EUR 153.3
Description: Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V7038IHC-7ML 7 ml
EUR 349.3
Description: Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V7038SAF-100UG 100 ug
EUR 349.3
Description: Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V7319-100UG 100 ug
EUR 349.3
Description: This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than estrogen receptor (ER) alone. This MAb is excellent for immunohistochemical staining of formalin-fixed tissues.

Progesterone Receptor Antibody
V7319-20UG 20 ug
EUR 153.3
Description: This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than estrogen receptor (ER) alone. This MAb is excellent for immunohistochemical staining of formalin-fixed tissues.

Progesterone Receptor Antibody
V7319IHC-7ML 7 ml
EUR 349.3
Description: This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than estrogen receptor (ER) alone. This MAb is excellent for immunohistochemical staining of formalin-fixed tissues.

Progesterone Receptor Antibody
V7319SAF-100UG 100 ug
EUR 349.3
Description: This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than estrogen receptor (ER) alone. This MAb is excellent for immunohistochemical staining of formalin-fixed tissues.

Progesterone Receptor Antibody
V2224-100UG 100 ug
EUR 349.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone. This progesterone receptor antibody is excellent for immunohistochemical staining of formalin/paraffin tissues.

Progesterone Receptor Antibody
V2224-20UG 20 ug
EUR 153.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone. This progesterone receptor antibody is excellent for immunohistochemical staining of formalin/paraffin tissues.

Progesterone Receptor Antibody
V2224IHC-7ML 7 ml
EUR 349.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone. This progesterone receptor antibody is excellent for immunohistochemical staining of formalin/paraffin tissues.

Progesterone Receptor Antibody
V2224SAF-100UG 100 ug
EUR 349.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone. This progesterone receptor antibody is excellent for immunohistochemical staining of formalin/paraffin tissues.

Progesterone Receptor Antibody
V2225-100UG 100 ug
EUR 349.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V2225-20UG 20 ug
EUR 153.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V2225SAF-100UG 100 ug
EUR 349.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V2226-100UG 100 ug
EUR 349.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V2226-20UG 20 ug
EUR 153.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor Antibody
V2226SAF-100UG 100 ug
EUR 349.3
Description: This antibody is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of progesterone receptor has been suggested to reflect a intact estrogen regulatory machinery and therefore predict better clinical response to endocrine therapy than ER alone.

Progesterone Receptor (PR) Antibody
abx239773-100ug 100 ug
EUR 577.2

Progesterone Receptor (PR) Antibody
abx011372-100ul 100 ul
EUR 493.2

Progesterone receptor Antibody (HRP)
20-abx108639
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Progesterone receptor Antibody (FITC)
20-abx107219
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Progesterone receptor Antibody (Biotin)
20-abx105801
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Progesterone Receptor antibody (Ser190)
70R-37155 100 ug
EUR 418.8
Description: Rabbit Polyclonal Progesterone Receptor antibody (Ser190)

Progesterone Receptor (PGR) Antibody
20-abx110119
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody
20-abx174169
  • EUR 978.00
  • EUR 510.00
  • 1 mg
  • 200 ug

Progesterone Receptor (PGR) Antibody
abx217233-100ug 100 ug
EUR 526.8

Progesterone Receptor (PGR) Antibody
20-abx141002
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (PGR) Antibody
20-abx141043
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (PGR) Antibody
20-abx133276
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (PGR) Antibody
abx117208-100ug 100 ug
EUR 560.4

Progesterone Receptor (PGR) Antibody
20-abx324929
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody
20-abx325043
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody
abx330393-100ul 100 ul
EUR 510

Progesterone Receptor (PGR) Antibody
20-abx326788
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody
abx027179-400ul 400 ul
EUR 627.6

Progesterone Receptor (PGR) Antibody
abx027179-80l 80 µl
EUR 343.2

Progesterone Receptor (PGR) Antibody
abx030889-400ul 400 ul
EUR 627.6

Progesterone Receptor (PGR) Antibody
abx030889-80l 80 µl
EUR 343.2

Progesterone Receptor (PGR) Antibody
abx031241-400ul 400 ul
EUR 627.6

Progesterone Receptor (PGR) Antibody
abx031241-80l 80 µl
EUR 343.2

Progesterone Receptor (PGR) Antibody
abx025331-100ul 100 ul
EUR 627.6

Progesterone Receptor (PGR) Antibody
abx025332-400ul 400 ul
EUR 627.6

Progesterone Receptor (PGR) Antibody
abx025332-80l 80 µl
EUR 343.2

Progesterone Receptor (PGR) Antibody
abx016048-100ul 100 ul
EUR 493.2

Progesterone Receptor (PGR) Antibody
20-abx102047
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody
20-abx131387
  • EUR 493.20
  • EUR 159.60
  • EUR 1378.80
  • EUR 678.00
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Progesterone Receptor (PGR) Antibody
20-abx126356
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Progesterone Receptor (PGR) Antibody
20-abx339790
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Progesterone Receptor (PGR) Antibody
20-abx339976
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Progesterone Receptor (PGR) Antibody
20-abx001717
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Progesterone Receptor (PGR) Antibody
abx011378-100ug 100 ug
EUR 526.8

Progesterone Receptor (PGR) Antibody
abx011381-100ug 100 ug
EUR 526.8

Progesterone Receptor (PGR) Antibody
abx011382-100ul 100 ul
EUR 493.2

Progesterone Receptor (PGR) Antibody
20-abx159642
  • EUR 326.40
  • EUR 276.00
  • 100 ug
  • 50 ug

Progesterone Receptor (pS345) Antibody
abx217728-100ug 100 ug
EUR 526.8

Progesterone Receptor (pS190) Antibody
20-abx133275
  • EUR 376.80
  • EUR 560.40
  • EUR 243.60
  • 100 ul
  • 200 ul
  • 30 ul

Progesterone Receptor (pS190) Antibody
20-abx119535
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Progesterone Receptor(PR484) Antibody
BNCA0484-250 250uL
EUR 459.6
Description: Primary antibody against Progesterone Receptor(PR484), APC conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNCA0500-250 250uL
EUR 459.6
Description: Primary antibody against Progesterone Receptor(PR500), APC conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNCA0501-250 250uL
EUR 459.6
Description: Primary antibody against Progesterone Receptor(PR501), APC conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC800484-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR484), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC800484-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR484), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC800500-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR500), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC800500-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR500), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC800501-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR501), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC800501-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR501), CF680 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC810484-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR484), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC810484-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR484), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC810500-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR500), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC810500-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR500), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC810501-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR501), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC810501-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR501), CF680R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC940484-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR484), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC940484-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR484), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC940500-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR500), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC940500-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR500), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC940501-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR501), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC940501-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR501), CF594 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC700484-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR484), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC700484-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR484), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC700500-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR500), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC700500-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR500), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC700501-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR501), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC700501-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR501), CF770 conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC880484-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR484), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC880484-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR484), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC880500-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR500), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC880500-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR500), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC880501-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR501), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC880501-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR501), CF488A conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC400484-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR484), CF640R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC400484-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR484), CF640R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC400500-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR500), CF640R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR500) Antibody
BNC400500-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR500), CF640R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC400501-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR501), CF640R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR501) Antibody
BNC400501-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR501), CF640R conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC050484-100 100uL
EUR 238.8
Description: Primary antibody against Progesterone Receptor(PR484), CF405M conjugate, Concentration: 0.1mg/mL

Progesterone Receptor(PR484) Antibody
BNC050484-500 500uL
EUR 652.8
Description: Primary antibody against Progesterone Receptor(PR484), CF405M conjugate, Concentration: 0.1mg/mL
Furthermore, a number of current research recommend that manipulation of the GM of laboratory mice can considerably enhance the predictive energy or translatability of information generated in mouse fashions to the human situations beneath investigation. This overview supplies readers with info associated to those varied elements and practices, and suggestions concerning strategies by which points with poor reproducibility or translatability may be reworked into discoveries.

Leave a Reply

Your email address will not be published. Required fields are marked *